...
首页> 外文期刊>Bioconjugate Chemistry >Activatable Near-Infrared Fluorescent Probe for In Vivo Imaging of Fibroblast Activation Protein-alpha
【24h】

Activatable Near-Infrared Fluorescent Probe for In Vivo Imaging of Fibroblast Activation Protein-alpha

机译:用于成纤维细胞活化蛋白-α体内成像的可激活近红外荧光探针

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fibroblast activation protein-alpha (FAPa) is a cell surface glycoprotein which is selectively expressed by tumor-associated fibroblasts in malignant tumors but rarely on normal tissues. FAPa has also been reported to promote tumor growth and invasion and therefore has been of increasing interest as a promising target for designing tumor-targeted drugs and imaging agents. Although medicinal studyon FAPa inhibitors has led to the discovery of many FAPa-targeting inhibitors including a drug candidate in a phase II clinical trial, the development of imaging probes to monitor the expression and activity of FAPa in vivo has largely lagged behind. Herein, we report an activatable near-infrared (NIR) fluorescent probe (ANP_(FAP)) for in vivo optical imaging of FAPa. The ANP_(FAP) consists of a NIR dye (Cy5.5) and a quencher dye (QSY21) which are linked together by a short peptide sequence (KGPGPNQC) specific for FAPa cleavage. Because of the efficient fluorescence resonance energy transfer (FRET) between CyS.5 arid QSY21 in ANP_(FAP), high contrast on the NIR fluorescence signal can be achieved after the cleavage of the peptide sequence by FAPa both in vitro and in vivo. In vitro assay on ANP_(FAP) indicated the specificity of the probe to FAPa. The in vivo optical imaging using ANP_(FAP) showed fast tumor uptake as well as high tumor to background contrast on U87MG tumor models with FAPa expression, while much lower signal and tumor contrast were observed in the C6 tumor without FAPa expression, demonstrating the in vivo targeting specificity of the ANP_(FAP). Ex vivo imaging also demonstrated ANP_(FAP) had high tumor uptake at 4 h post injection. Collectively, these results indicated that ANP_(FAP) could serve as a useful NIR optical probe for early detection of FAPa expressing tumors.
机译:成纤维细胞活化蛋白-α(FAPa)是一种细胞表面糖蛋白,由恶性肿瘤中的肿瘤相关成纤维细胞选择性表达,但在正常组织中很少表达。还已经报道了FAPa促进肿瘤生长和侵袭,因此作为设计靶向肿瘤的药物和显像剂的有希望的靶标,FAPa受到越来越多的关注。尽管有关FAPa抑制剂的药物研究已导致在II期临床试验中发现了许多靶向FAPa的抑制剂,包括候选药物,但在体内监测FAPA的表达和活性的成像探针的开发却远远滞后。在此,我们报告了一种用于FAPa体内光学成像的可激活近红外(NIR)荧光探针(ANP_(FAP))。 ANP_(FAP)由NIR染料(Cy5.5)和猝灭剂染料(QSY21)组成,它们通过对FAPa裂解具有特异性的短肽序列(KGPGPNQC)连接在一起。由于ANP_(FAP)中CyS.5和QSY21之间的有效荧光共振能量转移(FRET),在体外和体内通过FAPa裂解肽序列后,都可以在NIR荧光信号上实现高对比度。在ANP_(FAP)上的体外测定表明探针对FAPa的特异性。使用ANP_(FAP)进行的体内光学成像显示,在具有FAPa表达的U87MG肿瘤模型中,肿瘤的摄取速度快,并且肿瘤与背景的对比度高,而在没有FAPa表达的C6肿瘤中观察到的信号和肿瘤对比度低得多,这表明ANP_(FAP)的体内靶向特异性。体外成像还表明,ANP_(FAP)在注射后4小时具有很高的肿瘤吸收率。总体而言,这些结果表明,ANP_(FAP)可以作为有用的NIR光学探针,用于早期检测表达FAPa的肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号